Cambiar Aggressive Value ETF (CAMX)
NYSEARCA: CAMX · Real-Time Price · USD
30.44
+0.01 (0.03%)
At close: May 13, 2025, 4:00 PM
30.44
0.00 (0.00%)
After-hours: May 13, 2025, 8:00 PM EDT
2.27%
Assets $57.65M
Expense Ratio 0.59%
PE Ratio 16.83
Shares Out 1.95M
Dividend (ttm) $0.39
Dividend Yield 1.28%
Ex-Dividend Date Dec 30, 2024
Payout Ratio 21.48%
1-Year Return +2.24%
Volume 213
Open 30.44
Previous Close 30.43
Day's Range 30.44 - 30.47
52-Week Low 26.45
52-Week High 31.71
Beta 0.80
Holdings 26
Inception Date Feb 13, 2023

About CAMX

Fund Home Page

The Cambiar Aggressive Value ETF (CAMX) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed, global equity fund. Stock selection and weighting is based on the Issuers strongest belief for long-term capital appreciation. CAMX was launched on Feb 13, 2023 and is issued by Cambiar Funds.

Asset Class Equity
Category Global Large-Stock Value
Region Global
Stock Exchange NYSEARCA
Ticker Symbol CAMX
ETF Provider Cambiar Funds

Top 10 Holdings

53.30% of assets
Name Symbol Weight
Cash n/a 7.51%
Uber Technologies, Inc. UBER 6.90%
Delta Air Lines, Inc. DAL 6.24%
Elevance Health, Inc. ELV 6.04%
Nintendo Co., Ltd. NTDOY 4.85%
Energy Transfer LP ET 4.74%
Labcorp Holdings Inc. LH 4.48%
Airbus SE EADSY 4.40%
Flutter Entertainment plc FLUT 4.29%
Medtronic plc MDT 3.86%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Dec 30, 2024 $0.3884 Jan 7, 2025
Dec 28, 2023 $0.1464 Jan 5, 2024
Full Dividend History

News

Delta Earnings Showcase 2025 Worries & Active ETF Opportunities

While many market sectors are being troubled by macroeconomic uncertainty, the travel sector may very well have it the worst. Given the rise in inflationary pressures and recession risks, it could be ...

4 weeks ago - ETF Trends

Camurus announces positive Phase 3 results from the ACROINNOVA 2 study of octreotide SC depot (CAM2029) in acromegaly patients

Treatment well tolerated with a safety profile consistent with standard-of-care (SoC) Increased biochemical response rates (IGF-1 ≤ 1xULN) vs SoC at baseline Continuous improvement of acromegaly sympt...

10 months ago - PRNewsWire

Cambiar Investors Launches Aggressive Value ETF

DENVER--(BUSINESS WIRE)--Cambiar Investors announces the launch of a new active ETF.

2 years ago - Business Wire